このサイトは、私たちの説明に従ってクッキーを使用しています クッキーポリシー. 提供するCookieを確認するには、 クッキー設定パネル. このCookieポリシーに同意します、このメッセージを再度表示しないでください

Event on

Impact of ACR POC testing on the diagnosis and management of diabetic kidney disease

プレゼンテーション

  • PROF. GOTTFRIED RUDOFSKY

    PROF. GOTTFRIED RUDOFSKY
    (SWITZERLAND)
    Speaker

    Specialist in Internal Medicine – Endocrinology and Diabetology, Nephrology. Head of private practice in the fields of internal medicine and endocrinology, Olten, Switzerland

提示された見解および意見は、著者のみのものです。 このWebキャストに含まれるコンテンツは、情報提供/教育目的のみを目的としています。

背景

Chronic kidney disease is a common and often silent condition – up to one in ten adults could be affected in Europe, Canada and Israel, yet only one-third of these will have had a diagnosis1. Early detection can slow disease progression or even prevent it altogether1 — which is why testing in at-risk groups is so important.

Join this livestream series of 20 minutes each to learn how early detection can slow disease progression or even prevent it valtogether.

Our international speakers will discuss the role of rapid diagnostics in disease prevention, with point-of-care testing such as an Albumin Creatinine Ratio (ACR) assay, enabling healthcare providers to detect, and treat, kidney disease in minutes.

Learn more about current guidelines and kidney disease prevention and management.

Series of six livestream events covering:

  • Importance of regular testing for early detection and monitoring in high-risk patients
  • Importance of ACR testing beside the determination of eGFR
  • Latest guidance on disease prevention and management
  • Case studies
Share
Like
Tweet
References
  1. Sundström J, Bodegard J, Bollmann A et al. CaReMe CKD study: Prevalence, outcomes, and cost of CKD in a contemporary population of 2.4 million patients from 11 countries. The Lancet Regional Health – Europe 2022;00: 100438
  2. The International Society of Nephrology (ISN). Chronic Kidney Disease: HYPERLINK https://www.worldkidneyday.org/facts/chronic-kidney-disease.%20Accessed%201.%20September%202022 https://www.worldkidneyday.org/facts/chronic-kidney-disease. Accessed 1. September 2022

© 2022年のアボット。全著作権所有。参照されているすべての商標は、Abbottグループの企業またはそれぞれの所有者の商標です。 COL-00000

"-- SEO4AJAX --" "seo4ajax Access"

"-- SEO4AJAX --" "Init" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ja","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"}

"-- SEO4AJAX --" "Normalization A" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ja","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/ja/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Normalization B" {"hubsSlug":"mypocacademy","regionsSlug":"ww","languagesSlug":"ja","eventsSlug":"impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"} 200 "https://campus.meplis.com/mypocacademy/ww/ja/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Timeout: " 5 " seconds"

"-- SEO4AJAX --" "$window.onCaptureReady Called" 200 "https://campus.meplis.com/mypocacademy/ww/ja/events/impact-of-acr-poc-testing-on-the-diagnosis-and-management-of-diabetic-kidney-disease"

"-- SEO4AJAX --" "Bugsnag Called"